Delivery Order SPE2DB25D3110-SPE2DB25FTEKC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,740.99 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This competitively awarded, firm fixed-price delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors, with a contract ceiling value of $1,072.35 and an ultimate completion date of September 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $7,798.34 with a completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's broader pharmaceutical supply contract portfolio. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors, with a contract ceiling value of $5,466.66 and an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical medical supplies to support federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a contract ceiling value of $1,380.46 and an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside delivery order reflecting a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $8,343.63 and an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract represents a single delivery order transaction under AmerisourceBergen's existing pharmaceutical supply arrangements with the federal government. The place of performance...
- The Defense Logistics Agency awarded a $2,548.11 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors in 0.5 ml dosage units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside provisions were applied to this procurement. This delivery order is issued...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEKCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Trulicity, a diabetes medication, represents the type of specialty pharmaceutical commodity routinely procured through this vehicle to support the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains at varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/15/25 |